News
While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...
Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...
Alopecia areata causes patches of baldness about the size of a large coin - with both men and women equally affected. Kaz - donning her stylish cropped hairstyle - was back on-screen for the All ...
The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).
Corticosteroids can cause cataracts. As they are used to treat alopecia areata (AA) (at least in adults), all patients with AA, including those with single-patch AA, must be examined by an ...
Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...
Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...
Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.
Q32 Bio, of Waltham, Mass., announced on April 30, 2025 that its human anti-IL-7Rα antibody, bempikibart (ADX-914), has been given fast track designation by FDA for the treatment of alopecia areata ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results